Screener
Moderna MRNA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's operating lease liabilities?
- Moderna (MRNA) reported operating lease liabilities of $638M in Q2 2026.
- How has Moderna's operating lease liabilities changed year-over-year?
- Moderna's operating lease liabilities decreased by 4.2% year-over-year, from $666M to $638M.
- What is the long-term trend for Moderna's operating lease liabilities?
- Over 5 years (2020 to 2025), Moderna's operating lease liabilities has grown at a 46.4% compound annual growth rate (CAGR), from $97M to $653M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Moderna's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude